SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc. – ANTX
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AN2 Therapeutics, Inc. (“AN2” or the “Company”) (NASDAQ: ANTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext
EFFECTS OF ARGENTINA HYPERINFLATIONARY ACCOUNTING ON Q4 AND FULL YEAR 2023 RESULTS
“In a nutshell, due to the abrupt devaluation of the Argentine peso in late December, accounting rules required us to record a non-cash negative impact on our 4Q23 and full year 2023 earnings. But excluding this extraordinary accounting effect, our core business is solid with good prospects. W
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Silicon Laboratories Inc. – SLAB
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Silicon Laboratories Inc. (“Silicon Labs” or the “Company”) (NASDAQ: SLAB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Adtalem Global Education, Inc. – ATGE
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Adtalem Global Education, Inc. (“Adtalem” or the “Company”) (NYSE: ATGE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dun & Bradstreet Holdings, Inc. – DNB
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Dun & Bradstreet Holdings, Inc. (“DNB” or the “Company”) (NYSE: DNB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-99
Cboe NOW LISTS iSHARES BY BLACKROCK ETFs ACROSS ITS ENTIRE GLOBAL EXCHANGE NETWORK
Launch is major milestone in Cboe’s mission to build a global listings network and expand the investable universe for investorsBlackRock becomes first asset manager to list ETFs across Cboe’s entire global network of listings exchangesThe new ETFs, listed for trading on Cboe Australia, a
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lantronix, Inc. – LTRX
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Lantronix, Inc. (“Lantronix” or the “Company”) (NASDAQ: LTRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of D-Wave Quantum Inc. – QBTS
NEW YORK, Feb. 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of D-wave Quantum Inc. (“D-Wave” or the “Company”) (NYSE: QBTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7
Avidity Biosciences to Present New AOC 1001 Long-term Efficacy and Safety Data from MARINA-OLE™ Trial in People Living with Myotonic Dystrophy Type 1 (DM1) at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
John W. Day, MD, PhD, Professor of Neurology and Pediatrics, and Director, Division of Neuromuscular Medicine, Stanford University School of Medicine and a principal investigator in END-DM1, ongoing natural history study will join Avidity management to present data from MARINA-OLE™ Avidity to ho
Stoneridge, Inc. To Broadcast Its Fourth-Quarter 2023 Conference Call On The Web
NOVI, Mich., Feb. 15, 2024 /PRNewswire/ — Stoneridge, Inc. (NYSE: SRI) will webcast its fourth-quarter 2023 earnings conference call live on Thursday, February 29, 2024, at 9:00 a.m. ET with president and chief executive officer, Jim Zizelman, and chief financial officer, Matt Horvath. The w
